Estimation of transdermal permeation parameters in non-stationary diffusion experiments. Application to pre-treatment studies with terpenes

Pharmaceutical Research

Volumn 22, Issue 1, 2005, Pages 94-102

  Boix, A ^a   Peraire, C ^a   Obach, R ^a   Domenech, J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Finite dose diffusion model; Non modelistic parameters; Permeation enhancers; Permeation rate; Transdermal flux

Indexed keywords

ALCOHOL; ALPRAZOLAM; CINEOLE; DIAZEPAM; HEPTANE DERIVATIVE; LIMONENE; MENTHOL; MENTHONE; PENETRATION ENHANCING AGENT; PROPYLENE GLYCOL; TERPENE DERIVATIVE;

ADULT; ARTICLE; CELL TYPE; CONTROLLED STUDY; DRUG DIFFUSION; DRUG FORMULATION; DRUG PENETRATION; DRUG SCREENING; FEMALE; FINITE ELEMENT ANALYSIS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MATHEMATICAL MODEL; PRIORITY JOURNAL; SKIN PERMEABILITY; THEORETICAL STUDY;

ADMINISTRATION, CUTANEOUS; ADULT; DIFFUSION CHAMBERS, CULTURE; FEMALE; HUMANS; MIDDLE AGED; PERMEABILITY; SKIN ABSORPTION; SOLUBILITY; STATISTICS; TERPENES;

EID: 17644399430     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11095-004-9014-2     Document Type: Article

References (20)

1. D. A. Godwin and B. B. Michniak. Influence of drug lipophilicity on terpenes as transdermal penetration enhancers. Drug Dev. Ind. Pharm. 25:905-915 (1999).
2. A. C. Williams and B. W. Barry. The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (oestradiol) and hydrophilic (5-fluorouracil) drugs. Int. J. Pharm. 74:157-168 (1991).
3. A. C. Williams and B. W. Barry. Terpenes and the lipid-protein- partitioning theory of skin penetration enhancement. Pharm. Res. 8:17-24 (1991).
4. Y. Obata, K. Takayama, Y. Maitani, Y. Machida, and T. Nagai. Effect of pretreatment of skin with cyclic monoterpens on permeation of diclofenac in hairless rat. Biol. Pharm. Bull. 16:312-314 (1993).
5. B. J. Aungst, N.J. Rogers, and E. Shefter. Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides. Int. J. Pharm. 33:225-234 (1986).
6. M. Hashida, H. Okamoto, and H. Sezaki. Analysis of drug penetration through skin considering donor concentration decrease. J. Pharmacobiodyn. 11:636-644 (1988).
7. J. P. Skelly, V. P. Shah, H. I. Maibach, R. H. Guy, R. C. Wester, G. Flynn, and A. Yacobi. FDA and AAPS report of the Workshop on principles and practices of in vitro percutaneous penetration studies: relevance to bioavailability and bioequivalence. Pharm. Res. 3:265-267 (1987).
8. Skin absorption: in vitro method. Organization for Economic Cooperation and Development Guideline for Testing of Chemicals, n 428. December 2000.
9. R. H. Guy and J. Hadgraft. Physicochemical interpretation of the pharmacokinetics of percutaneous absorption. J. Pharmacokinet. Biopharm. 11:189-203 (1983).
10. H. Okamoto, H. Komatsu, M. Hashida, and H. Sezaki. Effects of β-cyclodextrin and di-o-methyl-β-cyclodextrin on the percutaneous absorption of butylparaben indomethacin and sulfanilic acid. Int. J. Pharm. 30:35-45 (1986).
11. W. T. Weeks. Numerical inversion of Laplace transforms using Laguerre functions. J. Assoc. Comput. Machinery 13:419-426 (1966).
12. D. Southwell, B. W. Barry, and R. Woodford. Variations in permeability of human skin within and between specimens. Int. J. Pharm. 18:229-309 (1984).
13. S. H. Yalkowsky. Techniques of Solubilization of Drugs, Marcel Dekker, New York, 1981
14. Y. G. Anissimov, S. E. Cross, and M. S. Roberts. Maximum flux as characterization of transdermal penetration. Perspective in Percutaneous Penetration 9A:60 (2004).
15. V. Carelli, G. Di Colo, E. Nannipieri, and M. F. Serafini. Enhancement effects in the percutaneous absorption of alprazolam through human skin in vitro. Drug Dev. Ind. Pharm. 20:1673-1681 (1994).
16. O. Shirakura, A. Ohshima, S. Tsunemi, S. Ishimaru, T. Sakaguchi, K. Takayama, and T. Nagai. Synergistic effect of d-limonene and ethanol on the transdermal permeation of NB-818. Drug Dev. Ind. Pharm. 21:411-425 (1995).
17. K. Sugibayashi, H. Nakamura, M. Shimoyama, T. Seki, and Y. Morimoto. Multicomponent systems to enhance skin permeability of drugs. In: K. R. Brain, V. J. James, and K. A. Walters (eds.), Prediction of Percutaneous Penetration-3B. Methods, Measurements, Modelling, STS Publishing, Cardiff, 1993
18. Y. Morimoto, K. Sugibayashi, D. Kobayashi, H. Shoji, J. Yamazaki, and M. Kimura. A new enhancer-coenhancer system to increase skin permeation of morphine hydrochloride in vitro. Int. J. Pharm. 91:9-14 (1993).
19. Y. G. Anissimov and M. S. Roberts. Diffusion modeling of percutaneous absorption kinetics: 3. Variable diffusion and partition coefficients, consequences for stratum corneum depth profiles and desorption kinetics. J. Pharm. Sci. 93:470-487 (2004).
20. M. Hori, H. I. Maibach, and R. H. Guy. Enhancement of propranolol hydrochloride and diazepam skin absorption in vitro. II: Drug, vehicle and enhancer penetration kinetics. J. Pharm. Sci. 81:330-333 (1992).